Primary versus castration-resistant prostate cancer: modeling through novel murine prostate cancer cell lines

被引:15
作者
Daoud, Georges [1 ]
Monzer, Alissar [1 ]
Bahmad, Hisham [1 ]
Chamaa, Farah [1 ]
Hamdar, Layal [1 ]
Mouhieddine, Tarek H. [1 ]
Shayya, Sami [1 ]
Eid, Assaad [1 ]
Kobeissy, Firas [2 ]
Liu, Yen-Nien [3 ]
Abou-Kheir, Wassim [1 ]
机构
[1] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Beirut, Lebanon
[2] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon
[3] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan
关键词
prostate cancer; castration-resistant prostate cancer; cancer stem cells; Pten; TP53; OXIDATIVE STRESS; EXPRESSION; TRANSITION; MECHANISMS; DOCETAXEL; GROWTH; BETA;
D O I
10.18632/oncotarget.8436
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cell lines representing the progression of prostate cancer (PC) from an androgen-dependent to an androgen-independent state are scarce. In this study, we used previously characterized prostate luminal epithelial cell line (Plum), under androgen influence, to establish cellular models of PC progression. Cells derived from orthotopic tumors have been isolated to develop an androgen-dependent (PLum-AD) versus an androgen-independent (PLum-AI) model. Upon immunofluorescent, qRT-PCR and Western blot analyses, PLum-AD cells mostly expressed prostate epithelial markers while PLum-AI cells expressed mesenchymal cell markers. Interestingly, both cell lines maintained a population of stem/progenitor cells. Furthermore, our data suggest that both cell lines are tumorigenic; PLum-AD resulted in an adenocarcinoma whereas PLum-AI resulted in a sarcomatoid carcinoma when transplanted subcutaneously in NOD-SCID mice. Finally, gene expression profiles showed enrichment in functions involved in cell migration, apoptosis, as well as neoplasm invasiveness and metastasis in PLum-AI cells. In conclusion, these data suggest that the newly isolated cell lines represent a new in vitro model of androgen-dependent and -independent PC.
引用
收藏
页码:28961 / 28975
页数:15
相关论文
共 50 条
[41]   Steroidogenesis in castration-resistant prostate cancer [J].
Shiota, Masaki ;
Endo, Satoshi ;
Blas, Leandro ;
Fujimoto, Naohiro ;
Eto, Masatoshi .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) :240-251
[42]   The biology of castration-resistant prostate cancer [J].
Lian, Fei ;
Sharma, Nitya V. ;
Moran, Josue D. ;
Moreno, Carlos S. .
CURRENT PROBLEMS IN CANCER, 2015, 39 (01) :17-28
[43]   Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate [J].
Yamamoto, Akiyuki ;
Kato, Masashi ;
Matsui, Hirotaka ;
Ishida, Ryo ;
Kimura, Tohru ;
Funahashi, Yasuhito ;
Sassa, Naoto ;
Matsukawa, Yoshihisa ;
Kamihira, Osamu ;
Hattori, Ryohei ;
Gotoh, Momokazu ;
Tsuzuki, Toyonori .
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2018, 23 (03) :584-590
[44]   Gli2 mediates the development of castration-resistant prostate cancer [J].
Xia, Lu ;
Bouamar, Hakim ;
Gu, Xiang ;
Zeballos, Carla ;
Qin, Tai ;
Wang, Bingzhi ;
Zhou, You ;
Wang, Yuhui ;
Yang, Junhua ;
Zhu, Haiyan ;
Zhang, Weishe ;
Houghton, Peter J. ;
Sun, Lu-Zhe .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 57 (01) :100-112
[45]   MiRNA 34a: a therapeutic target for castration-resistant prostate cancer [J].
Chalanqui, Marine J. ;
O'Doherty, Michelle ;
Dunne, Nicholas J. ;
McCarthy, Helen O. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (09) :1075-1085
[46]   Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer [J].
Haffner, Michael C. ;
Bhamidipati, Akshay ;
Tsai, Harrison K. ;
Esopi, David M. ;
Vaghasia, Ajay M. ;
Low, Jin-Yih ;
Patel, Radhika A. ;
Guner, Gunes ;
Pham, Minh-Tam ;
Castagna, Nicole ;
Hicks, Jessica ;
Wyhs, Nicolas ;
Aebersold, Ruedi ;
De Marzo, Angelo M. ;
Nelson, William G. ;
Guo, Tiannan ;
Yegnasubramanian, Srinivasan .
PROSTATE, 2021, 81 (15) :1159-1171
[47]   A Randomised Phase 2 Trial of Dexamethasone Versus Prednisolone in Castration-resistant Prostate Cancer [J].
Venkitaraman, Ramachandran ;
Lorente, David ;
Murthy, Vedang ;
Thomas, Karen ;
Parker, Lydia ;
Ahiabor, Ruth ;
Dearnaley, David ;
Huddart, Robert ;
De Bono, Johann ;
Parker, Chris .
EUROPEAN UROLOGY, 2015, 67 (04) :673-679
[48]   Catalase as a novel drug target for metastatic castration-resistant prostate cancer [J].
Giginis, Frantzeska ;
Wang, Joshua ;
Chavez, Aaron ;
Martins-Green, Manuela .
AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (06) :2644-+
[49]   Novel agents for castration-resistant prostate cancer: Early experience and beyond [J].
Fujimoto, Naohiro .
INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (02) :114-121
[50]   Synthesis of novel tanshinone derivatives for treatment of castration-resistant prostate cancer [J].
Xu, Defeng ;
Hu, Hang ;
Guan, Jing ;
Da, Jun ;
Xie, Yipeng ;
Liu, Yalin ;
Kong, Ren ;
Song, Guoqiang ;
Zhou, Huan .
CHEMICAL BIOLOGY & DRUG DESIGN, 2019, 94 (03) :1656-1663